Vaxart’s stock rallies 15% after it gets clearance to begin human trials of COVID-19 vaccine candidate – MarketWatch

Shares of Vaxart Inc. VXRT, +46.79% jumped 15.6% in premarket trading on Monday after the company said it had received the go-ahead from the Food and Drug Administration to begin testing its experimental oral COVID-19 vaccine in a Phase 1 clinical trial. Vaxart said it expects to begin recruiting participants for the open-label study sometime this month. Shares of the preclinical company have soared 1,412.1% so far this year, while the S&P 500 SPX, +1.27% is up 3.4%.

Read more here:

Vaxart's stock rallies 15% after it gets clearance to begin human trials of COVID-19 vaccine candidate - MarketWatch

Related Posts
Tags: